Student Research Committee, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran.
Preventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Arch Iran Med. 2023 Jan 1;26(1):1-7. doi: 10.34172/aim.2023.01.
Gynecologic cancers, including neoplasms of the cervix and uterine, are the fourth most common malignancies, causing 3.46% of deaths in women aged 15 to 59.
We aimed to report the Iranian National Population-based Cancer Registry (INPCR) results for Cervical and Uterine cancers in 2017.
The total population of Iran in 2017 was 80881792. INPCR collected data on cervical and uterine cancer incidence from 31 provinces of Iran. In this project, we retrospectively examined all the country's regions in terms of screening for the existence of these two cancers. The registry data bank in Iran was used.
Overall, 3481 new cervical and uterine cancer cases were registered in INPCR, including 842 cases of cervical cancer (with a crude rate of 1.04) and 2639 cases of uterine cancer (with a crude rate of 3.26). The average age-standardized incidence rate (ASR) was 0.99 for cervical cancer and 3.29 for uterine cancer. Out of 3481 new cervical and uterine cancer cases, 2887 were registered with pathological findings and 594 without pathological confirmation. In cervical cancers, the highest rate was related to squamous cell carcinoma, with 486 cases (57.72%).
Our results showed that Iran is a low-risk area for the incidence of cervical and uterine cancers. In this study, the highest rate of cervical cancer was related to squamous cell carcinoma, confirming previous reports. However, this rate was lower than previous studies and suggested an increase in other types of cervical cancer in Iran.
妇科癌症，包括宫颈和子宫肿瘤，是第四大常见恶性肿瘤，导致 15 至 59 岁女性死亡的 3.46%。
本研究旨在报告 2017 年伊朗全国基于人群的癌症登记处（INPCR）的宫颈癌和子宫癌结果。
2017 年伊朗的总人口为 80881792。INPCR 从伊朗 31 个省份收集了宫颈癌和子宫癌发病率的数据。在本项目中，我们回顾性地检查了所有国家地区对这两种癌症的筛查情况。伊朗的登记数据库被用于本研究。
INPCR 共登记了 3481 例新的宫颈癌和子宫癌病例，包括 842 例宫颈癌（粗发病率为 1.04）和 2639 例子宫癌（粗发病率为 3.26）。宫颈癌的平均年龄标准化发病率（ASR）为 0.99，子宫癌为 3.29。在 3481 例新的宫颈癌和子宫癌病例中，2887 例有病理发现，594 例无病理证实。在宫颈癌中，与鳞状细胞癌相关的比例最高，有 486 例（57.72%）。
我们的结果表明，伊朗是宫颈癌和子宫癌发病率低风险地区。在本研究中，宫颈癌的最高发病率与鳞状细胞癌有关，与以往的报告一致。然而，这一比例低于以往的研究，表明伊朗其他类型的宫颈癌有所增加。
